0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Diagnostic Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25B1669
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Diagnostic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Infectious Disease Diagnostic Testing Market Research Report 2025

Code: QYRE-Auto-25B1669
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Disease Diagnostic Testing Market Size

The global market for Infectious Disease Diagnostic Testing was valued at US$ 17700 million in the year 2024 and is projected to reach a revised size of US$ 22440 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Infectious Disease Diagnostic Testing Market

Infectious Disease Diagnostic Testing Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostic Testing.
The Infectious Disease Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Diagnostic Testing Market Report

Report Metric Details
Report Name Infectious Disease Diagnostic Testing Market
Accounted market size in year US$ 17700 million
Forecasted market size in 2031 US$ 22440 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Molecular Diagnostic Test
  • POC Infectious Disease Diagnostics Test
Segment by Application
  • HIV
  • HAIs
  • Respiratory
  • Tropical Diseases
  • Liver
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic, Siemens Healthcare Diagnostics, TECHLAB, Bio-Rad Laboratories, Corgenix, Cepheid, Meridian Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease Diagnostic Testing Market growing?

Ans: The Infectious Disease Diagnostic Testing Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Infectious Disease Diagnostic Testing Market size in 2031?

Ans: The Infectious Disease Diagnostic Testing Market size in 2031 will be US$ 22440 million.

Who are the main players in the Infectious Disease Diagnostic Testing Market report?

Ans: The main players in the Infectious Disease Diagnostic Testing Market are Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic, Siemens Healthcare Diagnostics, TECHLAB, Bio-Rad Laboratories, Corgenix, Cepheid, Meridian Bioscience

What are the Application segmentation covered in the Infectious Disease Diagnostic Testing Market report?

Ans: The Applications covered in the Infectious Disease Diagnostic Testing Market report are HIV, HAIs, Respiratory, Tropical Diseases, Liver, Others

What are the Type segmentation covered in the Infectious Disease Diagnostic Testing Market report?

Ans: The Types covered in the Infectious Disease Diagnostic Testing Market report are Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnostic Test
1.2.3 POC Infectious Disease Diagnostics Test
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 HIV
1.3.3 HAIs
1.3.4 Respiratory
1.3.5 Tropical Diseases
1.3.6 Liver
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostic Testing Market Perspective (2020-2031)
2.2 Global Infectious Disease Diagnostic Testing Growth Trends by Region
2.2.1 Global Infectious Disease Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease Diagnostic Testing Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease Diagnostic Testing Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease Diagnostic Testing Market Dynamics
2.3.1 Infectious Disease Diagnostic Testing Industry Trends
2.3.2 Infectious Disease Diagnostic Testing Market Drivers
2.3.3 Infectious Disease Diagnostic Testing Market Challenges
2.3.4 Infectious Disease Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Diagnostic Testing Players by Revenue
3.1.1 Global Top Infectious Disease Diagnostic Testing Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease Diagnostic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease Diagnostic Testing Revenue
3.4 Global Infectious Disease Diagnostic Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostic Testing Revenue in 2024
3.5 Global Key Players of Infectious Disease Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Infectious Disease Diagnostic Testing, Product and Application
3.7 Global Key Players of Infectious Disease Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostic Testing Breakdown Data by Type
4.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Type (2026-2031)
5 Infectious Disease Diagnostic Testing Breakdown Data by Application
5.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease Diagnostic Testing Market Size (2020-2031)
6.2 North America Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease Diagnostic Testing Market Size by Country (2020-2025)
6.4 North America Infectious Disease Diagnostic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostic Testing Market Size (2020-2031)
7.2 Europe Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease Diagnostic Testing Market Size by Country (2020-2025)
7.4 Europe Infectious Disease Diagnostic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostic Testing Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Diagnostic Testing Market Size (2020-2031)
9.2 Latin America Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease Diagnostic Testing Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease Diagnostic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostic Testing Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Disease Diagnostic Testing Introduction
11.2.4 Abbott Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 bioMerieux
11.3.1 bioMerieux Company Details
11.3.2 bioMerieux Business Overview
11.3.3 bioMerieux Infectious Disease Diagnostic Testing Introduction
11.3.4 bioMerieux Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.3.5 bioMerieux Recent Development
11.4 Diasorin
11.4.1 Diasorin Company Details
11.4.2 Diasorin Business Overview
11.4.3 Diasorin Infectious Disease Diagnostic Testing Introduction
11.4.4 Diasorin Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.4.5 Diasorin Recent Development
11.5 Roche Diagnostic
11.5.1 Roche Diagnostic Company Details
11.5.2 Roche Diagnostic Business Overview
11.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Introduction
11.5.4 Roche Diagnostic Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.5.5 Roche Diagnostic Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Infectious Disease Diagnostic Testing Introduction
11.6.4 BD Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.6.5 BD Recent Development
11.7 Gold Standard Diagnostics
11.7.1 Gold Standard Diagnostics Company Details
11.7.2 Gold Standard Diagnostics Business Overview
11.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Introduction
11.7.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.7.5 Gold Standard Diagnostics Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Disease Diagnostic Testing Introduction
11.8.4 Hologic Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.8.5 Hologic Recent Development
11.9 Siemens Healthcare Diagnostics
11.9.1 Siemens Healthcare Diagnostics Company Details
11.9.2 Siemens Healthcare Diagnostics Business Overview
11.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Introduction
11.9.4 Siemens Healthcare Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.9.5 Siemens Healthcare Diagnostics Recent Development
11.10 TECHLAB
11.10.1 TECHLAB Company Details
11.10.2 TECHLAB Business Overview
11.10.3 TECHLAB Infectious Disease Diagnostic Testing Introduction
11.10.4 TECHLAB Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.10.5 TECHLAB Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Introduction
11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Corgenix
11.12.1 Corgenix Company Details
11.12.2 Corgenix Business Overview
11.12.3 Corgenix Infectious Disease Diagnostic Testing Introduction
11.12.4 Corgenix Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.12.5 Corgenix Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Infectious Disease Diagnostic Testing Introduction
11.13.4 Cepheid Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.13.5 Cepheid Recent Development
11.14 Meridian Bioscience
11.14.1 Meridian Bioscience Company Details
11.14.2 Meridian Bioscience Business Overview
11.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Introduction
11.14.4 Meridian Bioscience Revenue in Infectious Disease Diagnostic Testing Business (2020-2025)
11.14.5 Meridian Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Infectious Disease Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Molecular Diagnostic Test
 Table 3. Key Players of POC Infectious Disease Diagnostics Test
 Table 4. Global Infectious Disease Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Infectious Disease Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Infectious Disease Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Infectious Disease Diagnostic Testing Market Share by Region (2020-2025)
 Table 8. Global Infectious Disease Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Infectious Disease Diagnostic Testing Market Share by Region (2026-2031)
 Table 10. Infectious Disease Diagnostic Testing Market Trends
 Table 11. Infectious Disease Diagnostic Testing Market Drivers
 Table 12. Infectious Disease Diagnostic Testing Market Challenges
 Table 13. Infectious Disease Diagnostic Testing Market Restraints
 Table 14. Global Infectious Disease Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Infectious Disease Diagnostic Testing Market Share by Players (2020-2025)
 Table 16. Global Top Infectious Disease Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2024)
 Table 17. Ranking of Global Top Infectious Disease Diagnostic Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Infectious Disease Diagnostic Testing, Headquarters and Area Served
 Table 20. Global Key Players of Infectious Disease Diagnostic Testing, Product and Application
 Table 21. Global Key Players of Infectious Disease Diagnostic Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Infectious Disease Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Infectious Disease Diagnostic Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Infectious Disease Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Infectious Disease Diagnostic Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Infectious Disease Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Infectious Disease Diagnostic Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Infectious Disease Diagnostic Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Infectious Disease Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Infectious Disease Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Infectious Disease Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Infectious Disease Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Infectious Disease Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Infectious Disease Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Infectious Disease Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott Infectious Disease Diagnostic Testing Product
 Table 49. Abbott Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 50. Abbott Recent Development
 Table 51. Abbott Company Details
 Table 52. Abbott Business Overview
 Table 53. Abbott Infectious Disease Diagnostic Testing Product
 Table 54. Abbott Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 55. Abbott Recent Development
 Table 56. bioMerieux Company Details
 Table 57. bioMerieux Business Overview
 Table 58. bioMerieux Infectious Disease Diagnostic Testing Product
 Table 59. bioMerieux Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 60. bioMerieux Recent Development
 Table 61. Diasorin Company Details
 Table 62. Diasorin Business Overview
 Table 63. Diasorin Infectious Disease Diagnostic Testing Product
 Table 64. Diasorin Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 65. Diasorin Recent Development
 Table 66. Roche Diagnostic Company Details
 Table 67. Roche Diagnostic Business Overview
 Table 68. Roche Diagnostic Infectious Disease Diagnostic Testing Product
 Table 69. Roche Diagnostic Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 70. Roche Diagnostic Recent Development
 Table 71. BD Company Details
 Table 72. BD Business Overview
 Table 73. BD Infectious Disease Diagnostic Testing Product
 Table 74. BD Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 75. BD Recent Development
 Table 76. Gold Standard Diagnostics Company Details
 Table 77. Gold Standard Diagnostics Business Overview
 Table 78. Gold Standard Diagnostics Infectious Disease Diagnostic Testing Product
 Table 79. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 80. Gold Standard Diagnostics Recent Development
 Table 81. Hologic Company Details
 Table 82. Hologic Business Overview
 Table 83. Hologic Infectious Disease Diagnostic Testing Product
 Table 84. Hologic Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 85. Hologic Recent Development
 Table 86. Siemens Healthcare Diagnostics Company Details
 Table 87. Siemens Healthcare Diagnostics Business Overview
 Table 88. Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Product
 Table 89. Siemens Healthcare Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 90. Siemens Healthcare Diagnostics Recent Development
 Table 91. TECHLAB Company Details
 Table 92. TECHLAB Business Overview
 Table 93. TECHLAB Infectious Disease Diagnostic Testing Product
 Table 94. TECHLAB Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 95. TECHLAB Recent Development
 Table 96. Bio-Rad Laboratories Company Details
 Table 97. Bio-Rad Laboratories Business Overview
 Table 98. Bio-Rad Laboratories Infectious Disease Diagnostic Testing Product
 Table 99. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 100. Bio-Rad Laboratories Recent Development
 Table 101. Corgenix Company Details
 Table 102. Corgenix Business Overview
 Table 103. Corgenix Infectious Disease Diagnostic Testing Product
 Table 104. Corgenix Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 105. Corgenix Recent Development
 Table 106. Cepheid Company Details
 Table 107. Cepheid Business Overview
 Table 108. Cepheid Infectious Disease Diagnostic Testing Product
 Table 109. Cepheid Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 110. Cepheid Recent Development
 Table 111. Meridian Bioscience Company Details
 Table 112. Meridian Bioscience Business Overview
 Table 113. Meridian Bioscience Infectious Disease Diagnostic Testing Product
 Table 114. Meridian Bioscience Revenue in Infectious Disease Diagnostic Testing Business (2020-2025) & (US$ Million)
 Table 115. Meridian Bioscience Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Infectious Disease Diagnostic Testing Picture
 Figure 2. Global Infectious Disease Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Disease Diagnostic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Molecular Diagnostic Test Features
 Figure 5. POC Infectious Disease Diagnostics Test Features
 Figure 6. Global Infectious Disease Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Infectious Disease Diagnostic Testing Market Share by Application: 2024 VS 2031
 Figure 8. HIV Case Studies
 Figure 9. HAIs Case Studies
 Figure 10. Respiratory Case Studies
 Figure 11. Tropical Diseases Case Studies
 Figure 12. Liver Case Studies
 Figure 13. Others Case Studies
 Figure 14. Infectious Disease Diagnostic Testing Report Years Considered
 Figure 15. Global Infectious Disease Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Infectious Disease Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Infectious Disease Diagnostic Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Infectious Disease Diagnostic Testing Market Share by Players in 2024
 Figure 19. Global Top Infectious Disease Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostic Testing Revenue in 2024
 Figure 21. North America Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Infectious Disease Diagnostic Testing Market Share by Country (2020-2031)
 Figure 23. United States Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Infectious Disease Diagnostic Testing Market Share by Country (2020-2031)
 Figure 27. Germany Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Infectious Disease Diagnostic Testing Market Share by Region (2020-2031)
 Figure 35. China Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Infectious Disease Diagnostic Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Infectious Disease Diagnostic Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Infectious Disease Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Abbott Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 51. Abbott Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 52. bioMerieux Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 53. Diasorin Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 54. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 55. BD Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 56. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 57. Hologic Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 58. Siemens Healthcare Diagnostics Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 59. TECHLAB Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 61. Corgenix Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 62. Cepheid Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 63. Meridian Bioscience Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS